Back to stacks
StackMetabolic
Apex Lean Stack
Stacks Retatrutide's triple agonism (GLP-1/GIP/glucagon) with Tirzepatide cycling and MOTS-c mitochondrial signaling. Studied for visceral adipose reduction with preserved lean mass in male models.
In this stack
Save 20% when added as a full stack
Protocol notes
How it's studied
Alternating Retatrutide and Tirzepatide titration blocks with continuous MOTS-c. Endpoints: visceral fat, DEXA lean mass, HbA1c.
Mechanisms
Pathways at a glance
- Retatrutide: GLP-1 / GIP / glucagon triple agonism
- Tirzepatide: dual GLP-1 / GIP
- MOTS-c: AMPK pathway, mitochondrial biogenesis
Products described above are sold strictly for laboratory research. They are not for human consumption, therapeutic use, diagnosis, or treatment. Stacks reflect research patterns reported in published literature and are not protocols, dosing recommendations, or medical advice.
Other men's stacks
Hormone
HPG Foundation
Kisspeptin, CJC-1295 and Ipamorelin — pulsatile axis and growth-hormone pathway research.
Explore RecoveryWolverine Recovery
BPC-157 and TB-500 paired with GHK-Cu — tendon, ligament and skin repair literature.
Explore LongevityLongevity Base
NAD+, Epitalon and Glutathione — mitochondrial, telomerase and antioxidant pathways.
Explore